Notice of Results

RNS Number : 0149O

Hutchison China Meditech Limited

27 February 2009

 



Hutchison China MediTech Limited ('Chi-Med')

(AIM: HCM)

Notice of Announcement of 2008 Final Results

London: Friday, 27 February 2009: Chi-Med will be announcing its final results for the year ended 
31 December 2008 on Monday, 16 March 2009.

Enquiries

Chi-Med   Christian Hogg, CEO	Telephone: [phone]
Citigate Dewe Rogerson   Anthony Carlisle   David Dible	Telephone: [phone] [phone] [phone]

About Chi-Med

Chi-Med is the holding company of a pharmaceutical and healthcare group based primarily in China and was admitted to trading on the Alternative Investment Market of the London Stock Exchange in May 2006. It is focused on researching, developing, manufacturing, and selling pharmaceuticals, health supplements and other consumer health and personal care products derived from Traditional Chinese Medicine and botanical ingredients. 

Chi-Med is majority owned by Hutchison Whampoa Limited, an international company listed on the Main Board of The Stock Exchange of Hong Kong Limited.

 

END

 

 

NORMGGZZMNGGLZM